Phase II study with prolonged infusion gemcitabine in pretreated advanced soft tissue sarcomas of the adult

被引：1
|
作者：
Späth-Schwalbe, E
Genvresse, I
Koschuth, A
Grunewald, R
Possinger, K
机构：
[1] Charite Univ Hosp, Berlin, Germany
[2] Humboldt Univ, Berlin, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81503-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1083
引用
收藏
页码：S271 / S271
页数：1
相关论文
共 50 条
  • [21] Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study
    Ferraresi, Virginia
    Ciccarese, Mariangela
    Cercato, Maria Cecilia
    Nuzzo, Carmen
    Zeuli, Massimo
    Di Filippo, Franco
    Giannarelli, Diana
    Cognetti, Francesco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 149 - 155
  • [22] Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group
    Reichardt, P.
    Nielsen, O. S.
    Bauer, S.
    Hartmann, J. T.
    Schoffski, P.
    Christensen, T. B.
    Pink, D.
    Daugaard, S.
    Marreaud, S.
    van Glabbeke, M.
    Blay, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) : 1017 - 1022
  • [23] Phase II trial of gemcitabine in advanced sarcomas
    Okuno, S
    Edmonson, J
    Mahoney, M
    Buckner, JG
    Frytak, S
    Galanis, E
    CANCER, 2002, 94 (12) : 3225 - 3229
  • [24] Phase lb study of decitabine in combination with gemcitabine in treatment of advanced soft tissue and bone sarcomas.
    Monga, Varun
    Dodd, Rebecca
    Scherer, Amanda
    Gutierrez, Wade Robert
    Tanas, Munir
    Mott, Sarah L.
    Milhem, Mohammed M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas
    Braemswig, Kira
    Ploner, Ferdinand
    Martel, Alexandra
    Bauernhofer, Thomas
    Hilbe, Wolfgang
    Kuehr, Thomas
    Leitgeb, Clemens
    Mlineritsch, Brigitte
    Petzer, Andreas
    Seebacher, Veronika
    Stoeger, Herbert
    Girschikofsky, Michael
    Hochreiner, Gerhard
    Ressler, Sigrun
    Romeder, Franz
    Woell, Ewald
    Brodowicz, Thomas
    ANTI-CANCER DRUGS, 2014, 25 (07) : 848 - 853
  • [26] PHASE-II STUDY OF MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT - AN EORTC-SOFT-TISSUE-AND-BONE-SARCOMA-GROUP STUDY
    VERWEIJ, J
    KRZEMIENIECKI, K
    KOK, T
    POVEDA, A
    VANPOTTELSBERGHE, C
    VANGLABBEKE, M
    MOURIDSEN, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (02) : 208 - 209
  • [27] Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study
    Palumbo, R
    Neumaier, C
    Cosso, M
    Bertero, G
    Raffo, P
    Spadini, N
    Valente, S
    Villani, G
    Pastorino, M
    Toma, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (01) : 66 - 72
  • [28] Gemcitabine in heavily pretreated adult soft tissue sarcoma patients
    Schoeler, D.
    Kunitz, A.
    Reichardt, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas
    Sonnenblick, Amir
    Eleyan, Feras
    Peretz, Tamar
    Ospovat, Inna
    Merimsky, Ofer
    Sella, Tamar
    Peylan-Ramu, Nili
    Katz, Daniela
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 829 - 832
  • [30] Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Patrizia Vici
    Alessandra Fabi
    Giulio Metro
    Domenico Sergi
    Diana Giannarelli
    Luigi Di Lauro
    Gerold Bepler
    Federica Tomao
    Francesco Cognetti
    Francesca Conti
    Massimo Lopez
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 687 - 693
12345